Dr. Katelynn Madill-Thomsen compares MMDx vs histology in >1,500 EMBs (INTERHEART + Trifecta-Heart): ⬆️ High discordance rate ⚖️ When MMDx and histology disagreed, DSA and dd-cfDNA aligned with MMDx 👉Histology may miss rejection, specially ABMR #ISHLT2025

👑 The king under fire? In the SHORE registry, patients with abnormal DNIT (GEP↑ + dd-cfDNA↑) but negative EMB had worse outcomes, primarily driven by graft dysfunction. 💣 Is it time to dethrone EMB as the gold standard? #ISHLT2025 Nir Uriel, MD MSc

What is the role of #Apixaban in #LVAD? Ian B. Hollis The ISHLT ⭐️Overview of prospective trials w/ no thrombotic events at 6 mo follow up and low bleeding events ⭐️Selection Criteria & Reversal Strategy being key components to consider

Are we all being too picky when it comes to increased LV wall thickness on donor hearts? Perhaps yes. Dr Christian O’Donnell Stanford Medicine presents intriguing insights on how we might refine the process.

Dr.Veli Topkara presents a new renal risk score predicting AKI requiring dialysis after heart transplant. Derived from >15,000 UNOS patients (2018–2024) 🔺High-risk (score >6) → 24% dialysis, ↓ 5-yr graft survival 💡 May help to better individualize risks. #ISHLT2025